AI assistant
Sending…
WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2019
Feb 21, 2019
30339_dirs_2019-02-21_dbba62d5-adb4-4f95-8bda-c8776341c2b4.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2019-02-19
Reporting Person: Abraham Silji (N/A)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-02-19 | Stock Options (Right to buy) | $102.51 | A | 8160.00 | Acquired | 2029-02-19 | Common Stock (8160.00) | Direct |
Footnotes
F1: This award vests in four equal annual installments beginning on February 19, 2020.
More from WEST PHARMACEUTICAL SERVICES INC
Board/Management Information
2026
Jun 1
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 11
Regulatory Filings
2026
May 5
Major Shareholding Notification
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Interim / Quarterly Report
2026
Apr 23
Regulatory Filings
2026
Apr 23
Major Shareholding Notification
2026
Mar 27